BIOLASE Inc (NASDAQ:BIOL)

2.17
Delayed Data
As of Mar 02
 0.00 / 0.00%
Today’s Change
1.69
Today|||52-Week Range
3.30
-17.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$126.1M

Company Description

BIOLASE, Inc. is a medical technology company that develops, manufactures, and markets lasers in dentistry and medicine. It also markets and distributes dental imaging equipment and other related products designed to improve technologies for applications and procedures in dentistry and medicine. The company offers two categories of laser system products: Waterlase systems and Diode systems. Its flagship product category, the Waterlase system, uses a patented combination of water and laser to perform most procedures, performs using dental drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. It also offers a family of Diode laser system products, including its ezlase soft tissue diode laser, to perform soft tissue and cosmetic procedures, including tooth whitening. The company also manufactures and sells accessories and disposables for its laser systems, such as hand pieces, laser tips and tooth whitening gel. BIOLASE was founded in 1987 and is headquartered in Irvine, CA.

Contact Information

BIOLASE, Inc.
4 Cromwell
Irvine California 92618
P:(949) 361-1200
Investor Relations:

Employees

Shareholders

Other institutional41.12%
Mutual fund holders4.00%
Individual stakeholders22.55%

Top Executives

Jeffrey M. NugentPresident, Chief Executive Officer & Director
Dmitri BoutoussovVice President-Research & Development
Orlando P. RodriguesChief Marketing Officer & Vice President
William E. BrownVice President-Business Development
Richard R. WhippVice President-Operations

To view my watchlist

Not a member yet?

Sign up now for a free account